These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 37605497)
1. Epigenetic Regulation of the Expression of T Cell Stimulatory and Inhibitory Factors by Histone H3 Lysine Modification Enzymes and Its Prognostic Roles in Glioblastoma. Lee SH; Kim SH; Nam TM; Jang JH; Kim KH; Lee YS; Kim MS; Kim MS; Jin SY; Lee M; Lee SH; Kim YZ J Korean Med Sci; 2023 Aug; 38(33):e258. PubMed ID: 37605497 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter. Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma. Lee SH; Lee EH; Lee SH; Lee YM; Kim HD; Kim YZ J Korean Med Sci; 2015 Aug; 30(8):1157-66. PubMed ID: 26240495 [TBL] [Abstract][Full Text] [Related]
4. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer. Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831 [TBL] [Abstract][Full Text] [Related]
5. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study. Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636 [TBL] [Abstract][Full Text] [Related]
6. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas. Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer. Sasidharan Nair V; Toor SM; Taha RZ; Shaath H; Elkord E Clin Epigenetics; 2018 Aug; 10(1):104. PubMed ID: 30081950 [TBL] [Abstract][Full Text] [Related]
9. Modulation of immune checkpoint regulators in interferon γ induced urothelial carcinoma and activated T-lymphocyte cells by cytostatics. Hänze J; Schulte-Herbrüggen J; Hofmann R; Hegele A Genes Immun; 2023 Jun; 24(3):149-153. PubMed ID: 37138100 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome. Hodge G; Hodge S; Ahern J; Holmes-Liew CL; Reynolds PN; Holmes M Clin Exp Immunol; 2013 Jul; 173(1):150-60. PubMed ID: 23607447 [TBL] [Abstract][Full Text] [Related]
11. B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis. Lee JH; Kim YJ; Ryu HW; Shin SW; Kim EJ; Shin SH; Park JY; Kim SY; Hwang CS; Na JY; Shin DH; Kim JY; Lee HJ Diagn Pathol; 2023 Mar; 18(1):36. PubMed ID: 36894965 [TBL] [Abstract][Full Text] [Related]
12. Targeting the B7 family of co-stimulatory molecules: successes and challenges. Podojil JR; Miller SD BioDrugs; 2013 Feb; 27(1):1-13. PubMed ID: 23329394 [TBL] [Abstract][Full Text] [Related]
13. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma. Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY Front Immunol; 2021; 12():705378. PubMed ID: 34526987 [TBL] [Abstract][Full Text] [Related]
14. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells. Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655 [TBL] [Abstract][Full Text] [Related]
15. The landscape of de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488 [TBL] [Abstract][Full Text] [Related]
16. Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma. Kim HG; Kim MS; Lee YS; Lee EH; Kim DC; Lee SH; Kim YZ Cancer Res Treat; 2022 Jul; 54(3):690-708. PubMed ID: 34793663 [TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma. Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863 [TBL] [Abstract][Full Text] [Related]
18. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients. Karimi MH; Motazedian M; Abedi F; Yaghobi R; Geramizadeh B; Nikeghbalian S Gene; 2012 Aug; 504(1):127-32. PubMed ID: 22579879 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study. Tokić S; Štefanić M; Karner I; Glavaš-Obrovac L Endokrynol Pol; 2017; 68(3):274-828. PubMed ID: 28660994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]